RPA2 and breast carcinoma: MCM10 OE was able to increase RPA2 compared to controls in breast cancer patient biopsy and in MCF10A OE cells, which further induced high expression of downstream proteins ATR and CHEK1, supporting the possibility of increased ssDNA in MCM10 OE cells.